Company Profile:
SANOFI AVENTIS PAKISTAN LTD is primarily a pharmaceutical manufacturer (factory) with manufacturing facilities in Pakistan, and it also functions as a trader and distributor for its products within the country.
Company Introduction:
SANOFI AVENTIS PAKISTAN LTD is a prominent pharmaceutical company operating in Pakistan, serving as a subsidiary of Sanofi S.A., a global healthcare leader headquartered in France.
The company is deeply involved in the healthcare sector of Pakistan, focusing on the manufacturing, marketing, and distribution of a comprehensive portfolio of pharmaceutical products, vaccines, and consumer healthcare solutions. Sanofi Aventis Pakistan's operations cover a broad spectrum of therapeutic areas, including but not limited to diabetes, cardiovascular diseases, oncology, central nervous system disorders, and rare diseases.
With a significant and long-standing presence in Pakistan, SANOFI AVENTIS PAKISTAN LTD is recognized as one of the leading pharmaceutical players in the market. It plays a crucial role in providing access to essential medicines and innovative healthcare solutions to the Pakistani population. The company adheres to stringent international quality standards in its manufacturing processes, ensuring high-quality products. It also contributes to the local economy through job creation and investment in healthcare infrastructure.
Enterprise Products
Sanofi Aventis Pakistan Ltd. produces or sells a variety of pharmaceutical and healthcare products. These include diabetes care medications such as Lantus, Apidra, Toujeo, and Amaryl. In cardiovascular health, key products include Plavix and Clexane. The company also markets a range of vaccines including Vaxigrip Tetra, Adacel, Pentacel, and Hexaxim. For consumer healthcare, products like Allegra, Enterogermina, Dulcolax, and Buscopan are available. In oncology, Taxotere is among their offerings. Other significant products include Stemetil and Solian.